Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 2002;8(5):253–256. doi: 10.1155/MBD.2002.253

Cerebroprotective Effects of Dimeric Copper(II) Bis(o-acetoxybenzoate) on Ischemia-reperfusion Injury in Gerbils

Ling Li 1,✉, Zhiqiang Shen 1, Weimin Yang 1, Wanling Wu 1, Weiping Liu 2, Zhihe Chen 1
PMCID: PMC2365276  PMID: 18476002

Abstract

The cerebroprotective effects of copper aspirinate [dimeric copper(II) bis(o-acetoxybenzoate)] were investigated in gerbils subjected to 10-min global cerebral ischemia followed b 60-min reperfusion. The results showed that intragastric copper aspirinate (7.5, 15.0 and 30.0 mg Kg−1) markedly promoted the recovery of the electroencephalogram amplitude, attenuated the increase of lipid peroxide content and the decrease of superoxide dismutase activity in the cortex during ischemia-reperfusion injury. It suggested that copper aspirinate possesses potential neuroprotective properties, the mechanism of which might be related to an increase of the activity of endogenous superoxide dismutase.

Full Text

The Full Text of this article is available as a PDF (504.8 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES